鳳梨酵素 Bromelain × 骨關節炎

結論:證據支持

The evidence for oral bromelain in osteoarthritis is weak and does not support an efficacy claim.

C 🟠 C 薄弱證據 已發布 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 🇹🇼 台灣在地警示

The evidence for oral bromelain in osteoarthritis is weak and does not support an efficacy claim. The single double-blind placebo-controlled RCT (PMID 17121765, n=47, 800 mg/day, 12 weeks) found NO significant benefit on the primary WOMAC outcome (p=0.27) and explicitly concluded bromelain is not efficacious for moderate-to-severe knee OA. The apparently 'positive' literature relies on uncontrolled case series, single-blind diclofenac-equivalence pilots, and combination products (bromelain + trypsin + rutoside) that cannot isolate the effect of bromelain itself. Neither the ACR/Arthritis Foundation nor OARSI guidelines name or grade bromelain, and the 2023 meta-analysis pooled pain across many indications (sinusitis, surgery, OA) showing only a small effect (MD approximately -0.27) with no OA-specific pooled estimate. This matches Examine's grade D for Osteoarthritis Symptoms (no effect, 1 study, n=47), so an independent grade of D is the honest assessment.

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.47
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 已發布
信心度
77%
證據方向大致一致
證據層級
E3
單篇高品質統合分析

各層「支持此療效」的程度

分數越低=該層越不支持
L11 AI 複核獨立判讀
0.30
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L5 臨床機構權威立場
0.55
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.465
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Bromelain as an adjunctive treatment for moderate-to-severe osteoarthritis of the knee: a randomized placebo-controlled pilot study
PMID: 17121765 2006 RCT (double-blind) n = 47
結論:No statistically significant difference between bromelain and placebo for the primary outcome (total WOMAC, p=0.27). Only 31 of 47 enrolled completed; both groups improved only on the WOMAC disability subscale. Authors concluded bromelain is not efficacious as an adjunctive treatment for moderate-to-severe knee OA.
🟠 品質有限 效應量:Total WOMAC: no significant between-group difference (p=0.27)
前往 PubMed
Improved WOMAC score following 16-week treatment with bromelain for knee osteoarthritis
PMID: 27470088 2016 RCT (single-blind) n = 40
結論:At 4 weeks no significant difference between bromelain and diclofenac groups (both improved; 2 diclofenac patients withdrew for adverse effects). Within-group improvement at 16 weeks of bromelain: total WOMAC 12.2 vs 25.5 baseline, pain 2.4 vs 5.6, stiffness 0.8 vs 2.0, function 9.1 vs 17.9; SF-36 physical component and oxidative-stress markers also improved.
🟠 品質有限 效應量:Within-group total WOMAC reduction ~13 points at 16 weeks; no placebo arm
前往 PubMed
Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies
PMID: 15841258 2004 Other
結論:Reviewed 12 clinical studies (10 knee, 2 shoulder), mostly uncontrolled case series or comparisons against diclofenac. Bromelain looked promising and was comparable to diclofenac in some trials, but the evidence base was deemed inconclusive: short treatment periods, inadequate power, weak or absent follow-up, several unpublished studies, unclear optimal dose. Authors called for phase II trials before definitive efficacy testing.
🟠 品質有限 效應量:Not pooled; symptom reduction broadly comparable to diclofenac in equivalence trials
前往 PubMed
Efficacy and safety of bromelain: A systematic review and meta-analysis
PMID: 37157782 2023 統合分析
結論:54 articles reviewed qualitatively, 39 meta-analyzed across many indications. Oral bromelain showed a small but significant pain reduction (mean difference about -0.27 on pain scales). Moderate-quality studies indicated potential for oral bromelain in pain control; no major health risks reported. OA was only one of several indications and was not analyzed as an isolated pooled estimate.
效應量:Pooled pain MD approximately -0.27 (small; mixed indications, not OA-specific)
前往 PubMed

L4a US FDA
中性
Bromelain (CAS Reg. No. 9001-00-7) ... ENZYME, FLAVOR ENHANCER, FLAVORING AGENT OR ADJUVANT, PROCESSING AID, TEXTURIZER; GRAS, 21 CFR 184.1024 來源↗
L4b EU EFSA
反對
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
中性
酵素製劑屬食品添加物第(十七)類「其他」,可於各類食品中視實際需要適量使用,限於食品製造或加工必須時使用。 來源↗
L4e WHO
未表態
— 本適應症無對應資料

L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
中性
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
未表態

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

針對「鳳梨酵素 × 骨關節炎/退化性關節炎」這個特定組合,PTT/Dcard/Mobile01 幾乎沒有在地真實使用心得。台灣關節保健的社群討論幾乎全被葡萄糖胺、軟骨素、UC-II 非變性第二型膠原蛋白、MSM、薑黃素佔據,PTT 藥師板「常見關節保健品成分大解析」根本沒把鳳梨酵素列為關節成分,僅在『含鳳梨酵素者建議飯前吃』被一筆帶過;Mobile01 長輩膝蓋/關節保健串也是推 UC-II/MSM/薑黃,鮮少有人專為退化性關節炎吃鳳梨酵素。Dcard 上鳳梨酵素被熱議的內容幾乎都是脹氣、大餐救星、消化、減肥向,與膝關節退化無關。把鳳梨酵素和退化性關節炎連在一起的,主要是 FB 醫師貼文(『初期退化性關節炎不再只依賴消炎藥』)與營養師/媒體部落格科普(康健、良醫、learneating,引述每日 540–1890mg、500–800mg 等舊研究),而非鄉民實測回報。屬於『該保健品在此適應症下台灣社群討論稀薄、僅有商品頁與業配科普』的稀疏結果,不足以當作在地使用經驗證據。

💬社群實感

無共識(針對退化性關節炎此適應症,台灣社群幾乎無鳳梨酵素的實測心得;膝關節退化討論集中在葡萄糖胺/軟骨素/UC-II/MSM/薑黃)

破解迷思 社群最常見的 4 個誤解
事實把 FB 醫師貼文/媒體科普引述的『鳳梨酵素初期退化性關節炎可不再只依賴消炎藥、效果與 NSAID 相當』當成台灣鄉民實證共識(實為國外少量且分歧的舊研究,2018 Meta 分析未達顯著、800mg×12 週與安慰劑無差異,非社群實測)
事實誤以為鳳梨酵素是主流關節保健成分(台灣社群關節保養首選仍是葡萄糖胺、軟骨素、UC-II 膠原蛋白、MSM、薑黃,鳳梨酵素幾乎不被列入比較)
事實把『鳳梨酵素抗發炎、消腫』直接外推為『能修復或治療退化性關節炎軟骨磨損』(社群與研究主要談的是緩解疼痛/發炎,無逆轉退化的證據,且關節用劑量需 500mg 以上、遠高於市售消化型產品)
事實把市售消化/脹氣取向的鳳梨酵素產品(葡萄王益菌王、大餐救星類)當成可改善關節退化(兩者訴求、劑量與成分設計不同)

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

每顆含鳳梨酵素500毫克(2400GDU/g),用法為1次1顆,1天1次

代表來源 ↗
L10b · TFDA 法定身份 官方認定
🍽️一般食品

食品安全衛生管理法第28條規定,食品或食品添加物不能有相關醫療效能標示、宣傳或廣告,亦不得有不實、誇張或易生誤解之情形

來源 ↗

  • 陸上運動與肌力訓練
  • 減重(過重者)
  • 局部或口服 NSAID
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v25 engine_version: v1.0 claim_id: CLM-COND-osteoarthritis-INT-bromelain-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-osteoarthritis-INT-bromelain-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "鳳梨酵素能改善骨關節炎",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}